Silica Replicas Derived from Mammalian Cells as an Innovative Approach to Physically Direct Cell Lineage Decisions of Mesenchymal Stem Cells
Source abstract
Abstract
By means of a "live-cell" template strategy, silica replicas displaying the same morphology and topography of the mammalian cells used as templates are fabricated. The replicas are used as substrates to direct the differentiation of mesenchymal stem cells (MSCs) to predefined cell lineages. Upregulation of specific genes shows how the silica replica-based substrates have the ability to induce the molecular characteristics of the mature cell types from which they have been derived from. Thus, MSCs cultured in the presence of silica replicas of human osteoblasts (HObs) differentiate into HObs-like cells, as shown by the upregulation of specific osteogenic genes. Likewise, when MSCs are incubated with silica replicas derived from human chondrocytes, an enhanced expression of chondrogenic markers is observed. Importantly, the effects of the silica replicas are cell type-specific since the incubation of MSCs with HObs silica replicas does not result in upregulation of chondrogenic markers and vice versa. What is more, for both cases, the differentiation rate is enhanced when the silica replicas are used in combination with growth factors, suggesting a potential synergistic effect. These results demonstrate the potential of this innovative method as an efficient and cheap approach with the potential to eliminate, or at least reduce, the use of biochemically soluble compounds in stem cells research.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Cellular Mechanics and Interactions · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
DTU Health Tech, Centre for Nanomedicine and Theranostics, Technical University of Denmark, Produktionstorvet, Building 423, 2800 Kongens Lyngby, Denmark
Funding
Novo Nordisk Fonden
References (60)
Show source-provided references
1. 10.3390/nano1010207010.3390/nano10102070 ↗
2. 10.1021/acs.chemrev.7b0009410.1021/acs.chemrev.7b00094 ↗
3. 10.2217/nnm.14.22510.2217/nnm.14.225 ↗
4. 10.1021/nn403844q10.1021/nn403844q ↗
5. 10.1021/acsbiomaterials.6b0074110.1021/acsbiomaterials.6b00741 ↗
6. 10.1016/j.actbio.2016.09.03110.1016/j.actbio.2016.09.031 ↗
7. 10.1021/acs.biomac.0c0004510.1021/acs.biomac.0c00045 ↗
8. 10.3390/jfb203008810.3390/jfb2030088 ↗
9. 10.1021/nn303914810.1021/nn3039148 ↗
10. 10.1016/j.cell.2006.06.04410.1016/j.cell.2006.06.044 ↗
11. 10.1038/nmat201310.1038/nmat2013 ↗
12. 10.1016/j.biomaterials.2010.02.01210.1016/j.biomaterials.2010.02.012 ↗
13. 10.1073/pnas.081320010610.1073/pnas.0813200106 ↗
14. 10.1016/j.addr.2012.07.01410.1016/j.addr.2012.07.014 ↗
15. 10.1073/pnas.110986110810.1073/pnas.1109861108 ↗
16. 10.1089/scd.2009.011410.1089/scd.2009.0114 ↗
17. 10.1073/pnas.120581610910.1073/pnas.1205816109 ↗
18. 10.1002/adma.20140221310.1002/adma.201402213 ↗
19. 10.1038/ncomms666510.1038/ncomms6665 ↗
20. 10.1016/j.actbio.2019.11.03310.1016/j.actbio.2019.11.033 ↗
21. 10.1021/acsami.7b0114710.1021/acsami.7b01147 ↗
22. 10.1016/S0924-0136(02)00060-210.1016/S0924-0136(02)00060-2 ↗
23. 10.1016/j.proeng.2011.05.08610.1016/j.proeng.2011.05.086 ↗
24. 10.1371/journal.pone.010047510.1371/journal.pone.0100475 ↗
25. 10.1016/j.bone.2012.01.00710.1016/j.bone.2012.01.007 ↗
26. 10.1021/am501391z10.1021/am501391z ↗
27. 10.3390/ijms2117641810.3390/ijms21176418 ↗
28. 10.1016/j.msec.2020.11124510.1016/j.msec.2020.111245 ↗
29. 10.1016/j.biomaterials.2013.01.03510.1016/j.biomaterials.2013.01.035 ↗
30. 10.1016/j.biomaterials.2016.02.00410.1016/j.biomaterials.2016.02.004 ↗
31. 10.1039/C5RA22578G10.1039/C5RA22578G ↗
32. 10.1088/1748-605X/12/1/01500110.1088/1748-605X/12/1/015001 ↗
33. 10.1186/s13018-017-0534-y10.1186/s13018-017-0534-y ↗
34. 10.1038/s41598-017-08379-y10.1038/s41598-017-08379-y ↗
35. 10.1007/s12011-020-02183-y10.1007/s12011-020-02183-y ↗
36. 10.3390/cells808088610.3390/cells8080886 ↗
37. 10.1016/j.tice.2020.10133010.1016/j.tice.2020.101330 ↗
38. 10.1021/acsbiomaterials.1c0152510.1021/acsbiomaterials.1c01525 ↗
39. 10.3390/MA1404084310.3390/MA14040843 ↗
40. 10.1039/D0NA00692K10.1039/D0NA00692K ↗
41. 10.1021/cr300426x10.1021/cr300426x ↗
42. 10.1016/j.biomaterials.2011.11.04710.1016/j.biomaterials.2011.11.047 ↗
43. 10.1016/j.biomaterials.2012.12.01910.1016/j.biomaterials.2012.12.019 ↗
44. 10.1002/adhm.20150066410.1002/adhm.201500664 ↗
45. 10.1021/nn304966z10.1021/nn304966z ↗
46. 10.1021/nn504767g10.1021/nn504767g ↗
47. 10.1016/j.biomaterials.2013.06.01910.1016/j.biomaterials.2013.06.019 ↗
48. 10.2144/fsoa-2021-009710.2144/fsoa-2021-0097 ↗
49. 10.1002/advs.20200318610.1002/advs.202003186 ↗
50. 10.1002/ADFM.20200866210.1002/ADFM.202008662 ↗
51. 10.1021/acsami.9b0555310.1021/acsami.9b05553 ↗
52. 10.1038/s41598-021-87550-y10.1038/s41598-021-87550-y ↗
53. 10.3390/ijms2217940610.3390/ijms22179406 ↗
54. 10.1021/am503045b10.1021/am503045b ↗
55. 10.1002/biot.20140002010.1002/biot.201400020 ↗
56. 10.1039/C7BM00733G10.1039/C7BM00733G ↗
57. 10.1021/acsami.6b0330210.1021/acsami.6b03302 ↗
58. 10.1016/j.biomaterials.2012.07.00210.1016/j.biomaterials.2012.07.002 ↗
59. 10.3390/jfb1301000310.3390/jfb13010003 ↗
60. 10.3390/polym1301008310.3390/polym13010083 ↗